Answer
No, the safety and efficacy of Rapamune (sirolimus) in children and adolescents under 18 have not been established, and no dosing recommendation can be made.
Sources for this answer
- Rapamune 2 mg coated tabletsPfizer Limited · emc · SmPC §4.2 Posology and method of administration · Version 54Document updated
Sources checked